The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post-acute sequelae of SARS-CoV-2 infection in patients with cancer.
 
Jeremy Lyle Warner
Stock and Other Ownership Interests - HemOnc.org
Consulting or Advisory Role - Flatiron Health; Melax Tech; Roche; Westat
 
David J. James Pinato
Honoraria - Avammune; Bristol-Myers Squibb; Da Volterra; Mursla Bio; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Da Volterra; Eisai; H3 Biomedicine; Ipsen; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
Other Relationship - Wiley
 
Sanjay Mishra
Employment - MilliporeSigma (I)
Other Relationship - National Geographic
 
Renee Maria Saliby
No Relationships to Disclose
 
Clara Hwang
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I)
Consulting or Advisory Role - EMD Serono; Genzyme; TEMPUS
Speakers' Bureau - OncLive/MJH Life Sciences
Research Funding - AstraZeneca (Inst); Bausch Health (Inst); Bayer (Inst); Genentech (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Merck
 
Shuchi Gulati
Consulting or Advisory Role - Puma Biotechnology
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patent pending for: "Diagnostic tools for prediction of survival and responsiveness to treatments.” US17327100.
Travel, Accommodations, Expenses - Conquer Cancer Foundation
 
Rana R. McKay
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Exelixis; Janssen; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Sorrento Therapeutics; Tempus; Vividion Therapeutics
Research Funding - Bayer (Inst); Pfizer (Inst); Tempus (Inst)
 
Chris Labaki
Research Funding - Roche/imCORE
 
Elizabeth A. Griffiths
Honoraria - Novartis
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Genentech; Novartis; Otsuka; PicnicHealth; Taiho Oncology; Takeda
Research Funding - Apellis Pharmaceuticals (Inst); Astex Pharmaceuticals (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Celldex (Inst); Genentech (Inst)
 
Chinmay Jani
No Relationships to Disclose
 
Peter Paul Yu
Stock and Other Ownership Interests - Amazon; Apple; Contrafect; Danaher; Google; Microsoft
 
Andrew Jay Portuguese
No Relationships to Disclose
 
Matthew Puc
No Relationships to Disclose
 
Pamela Egan
No Relationships to Disclose
 
Sumit Shah
Honoraria - Janssen
Consulting or Advisory Role - Grand Rounds/Included Health; Natera
Research Funding - Genentech
 
Anup Kasi
Honoraria - OncLive
Research Funding - Astellas Pharma (Inst); Bavarian Nordic (Inst); Cardiff Oncology (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Halozyme (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
Travel, Accommodations, Expenses - Halozyme; Rafael Pharmaceuticals
 
Stephanie A. Berg
Honoraria - Aptitude Health
Consulting or Advisory Role - Bristol Meyers Squibb; Seattle Genetics/Astellas
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Eisai; Exelixis
Travel, Accommodations, Expenses - Eisai; Exelixis
 
Daniel Blake Flora
Other Relationship - Bexion
 
Melissa Kate Accordino
Honoraria - Incrowd; M3; Massive Bio; Sermo
Other Relationship - Onclive
 
Dimpy P Shah
No Relationships to Disclose